# Question 38

**Type:** Survival Analysis - Expression

**Question:** Do lung adenocarcinoma patients with high EGFR mRNA expression (top quartile) have different survival outcomes than those with low expression?

**Answer:**

**URL**: https://www.cbioportal.org/results/survival?Action=Submit&RPPA_SCORE_THRESHOLD=2.0&Z_SCORE_THRESHOLD=2.0&cancer_study_list=luad_tcga_pan_can_atlas_2018&case_set_id=luad_tcga_pan_can_atlas_2018_sequenced&data_priority=0&gene_list=EGFR&geneset_list=%20&genetic_profile_ids_PROFILE_COPY_NUMBER_ALTERATION=luad_tcga_pan_can_atlas_2018_gistic&genetic_profile_ids_PROFILE_MRNA_EXPRESSION=luad_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores&genetic_profile_ids_PROFILE_MUTATION_EXTENDED=luad_tcga_pan_can_atlas_2018_mutations&profileFilter=0&tab_index=tab_visualize

I've routed you to the **Survival tab** for EGFR in the TCGA PanCancer Atlas 2018 Lung Adenocarcinoma study.

On this page, you can:
- View Kaplan-Meier survival curves comparing patients with altered vs. unaltered EGFR
- Use the **"Split by EGFR mRNA expression quartiles"** option in the survival plot controls to compare top quartile (high expression) vs. bottom quartile (low expression)
- See overall survival and disease-free survival statistics
- Access log-rank test p-values to assess statistical significance

This will allow you to directly analyze whether high EGFR mRNA expression correlates with different survival outcomes in lung adenocarcinoma patients.

---

## Model Information
- **model**: us.anthropic.claude-sonnet-4-5-20250929-v1:0
- **temperature**: 0.0
- **max_output_tokens**: 1024
- **thinking_enabled**: False
- **thinking_budget_tokens**: 1024
- **response_time_seconds**: 8.285454196971841
- **agent_type**: cbio-nav-null

### Usage
- **input_tokens**: 559
- **output_tokens**: 423
- **total_tokens**: 982
- **cache_creation_input_tokens**: 0
- **cache_read_input_tokens**: 0

---

*Generated on 2026-02-05 01:38:42*